Angiogenesis

, Volume 3, Issue 3, pp 201–204

Long-term remission of Crohn's disease treated with thalidomide: A seminal case report

  • Steven J. Fishman
  • Neil R. Feins
  • Robert J. D'Amato
  • Judah Folkman
Article

DOI: 10.1023/A:1009027315912

Cite this article as:
Fishman, S.J., Feins, N.R., D'Amato, R.J. et al. Angiogenesis (1999) 3: 201. doi:10.1023/A:1009027315912

Abstract

A 31-year-old female with severe Crohn's disease for 15 years who had been treated with corticosteroids and 6-mercaptopurine, was treated with thalidomide initially for erythema nodosum. While on thalidomide all symptoms of Crohn's disease disappeared and she was able to discontinue all other drugs. At this writing she has been on thalidomide as sole therapy for over 4 years with the exception of a 5-week hiatus, during which time her symptoms recurred, but again disappeared after resumption of thalidomide therapy. This case suggests that thalidomide may be a useful therapy for Crohn's disease and provides impetus for a clinical trial of thalidomide for Crohn's disease.

angiogenesis angiogenesis inhibitor Crohn's disease thalidomide 

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Steven J. Fishman
    • 1
  • Neil R. Feins
    • 4
  • Robert J. D'Amato
    • 3
  • Judah Folkman
    • 2
  1. 1.Department of SurgeryChildren's HospitalUSA
  2. 2.Department of SurgeryCell Biology, Harvard Medical SchoolUSA
  3. 3.Department of OphthalmologyHarvard Medical SchoolUSA
  4. 4.Department of Pediatric SurgeryThe Tufts New England Medical CenterBostonUSA

Personalised recommendations